Detalhe da pesquisa
1.
Influencing factors of end-of-dose failure in patients with cancer pain after oral oxycodone sustained-release tablets: a retrospective, case-control study.
Jpn J Clin Oncol
; 51(6): 932-941, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33521814
2.
Effect of CYP2C9 genetic polymorphism and breviscapine on losartan pharmacokinetics in healthy subjects.
Xenobiotica
; 51(5): 616-623, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509019
3.
Development of the Practice of Pharmaceutical Care for Cancer Pain Management in Outpatient Clinics Using the Delphi Method.
Front Pharmacol
; 13: 840560, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35721109
4.
Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial.
JMIR Mhealth Uhealth
; 9(8): e24555, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398796
5.
Correction: Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial.
JMIR Mhealth Uhealth
; 9(9): e33223, 2021 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516388